NEW YORK, Jan 31 – Worried that Wall Street had completely turned its back on genomics companies, some investors — and executives — may be breathing a sigh of relief after applied genomics company Exact Sciences raised $56 million in an initial public offering on Wednesday.

In appraising the IPO climate some analysts noted that since the end of December, stock prices have begun to creep up out of the cellar, giving investors and companies alike a bit more confidence.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.